| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2021 ( Subtotal = $0 ) |
| | 2021 | 2018 | AUTOIMMUNE TECHNOLOGIES, LLC | 830 UNION ST STE 200 | NEW ORLEANS | LA | 70112-1421 | ORLEANS | USA | R41AI138722 | Double Chimeric Peptide Vaccine Feasible for Human Use that Protects against Disseminated Candidiasis caused by medically important Candida species | 000 | 1 | NIH | 3/11/2021 | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $224,645 ) |
| | 2018 | 2018 | AUTOIMMUNE TECHNOLOGIES, LLC | 830 UNION ST STE 200 | NEW ORLEANS | LA | 70112-1421 | ORLEANS | USA | R41AI138722 | Double Chimeric Peptide Vaccine Feasible for Human Use that Protects against Disseminated Candidiasis caused by medically important Candida species | 000 | 1 | NIH | 8/13/2018 | $224,645 |
|
| Issue Date FY: 2017 ( Subtotal = $0 ) |
| | 2017 | 2014 | AUTOIMMUNE TECHNOLOGIES, LLC | 830 UNION ST STE 200 | NEW ORLEANS | LA | 70112-1421 | ORLEANS | USA | R43AI112221 | Peptide inhibitors of coronavirus entry | 000 | 1 | NIH | 11/4/2016 | $0 |
|
| Issue Date FY: 2014 ( Subtotal = $225,000 ) |
| | 2014 | 2014 | AUTOIMMUNE TECHNOLOGIES, LLC | 1010 Common St Ste 1705 | New Orleans | LA | 70112-2460 | ORLEANS | USA | R43AI112221 | Peptide inhibitors of coronavirus entry | 000 | 1 | NIH | 6/10/2014 | $225,000 |
|
| Issue Date FY: 2011 ( Subtotal = $1,328,888 ) |
| | 2011 | 2011 | AUTOIMMUNE TECHNOLOGIES, LLC | 1010 Common St Ste 1705 | New Orleans | LA | 70112-2460 | ORLEANS | USA | R44AI082778 | PEPTIDE INHBITORS OF INFLUENZA ENTRY-FAST TRACK | 000 | 3 | NIH | 8/11/2011 | $1,328,888 |
|
| Issue Date FY: 2010 ( Subtotal = $1,305,089 ) |
| | 2010 | 2010 | AUTOIMMUNE TECHNOLOGIES, LLC | 1010 Common St Ste 1705 | New Orleans | LA | 70112-2460 | ORLEANS | USA | R44AI082778 | PEPTIDE INHBITORS OF INFLUENZA ENTRY-FAST TRACK | 000 | 2 | NIH | 8/30/2010 | $1,305,089 |
| | 2010 | 2009 | AUTOIMMUNE TECHNOLOGIES, LLC | 144 ELKS PLACE SUITE 1402 | NEW ORLEANS | LA | 70112 | ORLEANS | USA | R44AI082778 | PEPTIDE INHBITORS OF INFLUENZA ENTRY-FAST TRACK | 001 | 1 | NIH | 8/30/2010 | $0 |
|
| Issue Date FY: 2009 ( Subtotal = $1,304,709 ) |
| | 2009 | 2009 | AUTOIMMUNE TECHNOLOGIES, LLC | 1010 Common St Ste 1705 | New Orleans | LA | 70112-2460 | ORLEANS | USA | R44AI082778 | PEPTIDE INHBITORS OF INFLUENZA ENTRY-FAST TRACK | 000 | 1 | NIH | 6/2/2009 | $1,304,709 |
|
| Issue Date FY: 2007 ( Subtotal = $461,944 ) |
| | 2007 | 2007 | AUTOIMMUNE TECHNOLOGIES, LLC | 144 ELKS PLACE SUITE 1402 | NEW ORLEANS | LA | 70112 | ORLEANS | USA | R41AI068230 | PEPTIDE DRUGS AGAINST INFLUENZA VIRUS | 000 | 2 | NIH | 7/23/2007 | $461,944 |
|
| Issue Date FY: 2006 ( Subtotal = $560,795 ) |
| | 2006 | 2006 | AUTOIMMUNE TECHNOLOGIES, LLC | 144 ELKS PLACE SUITE 1402 | NEW ORLEANS | LA | 70112 | ORLEANS | USA | R41AI068221 | DEVELOPMENT OF MOLECULAR DIAGNOSTIC ASSAYS FOR SYSTEMIC AUTOIMMUNE DISEASES | 000 | 1 | NIH | 3/13/2006 | $99,838 |
| | 2006 | 2006 | AUTOIMMUNE TECHNOLOGIES, LLC | 144 ELKS PLACE SUITE 1402 | NEW ORLEANS | LA | 70112 | ORLEANS | USA | R41AI068230 | PEPTIDE DRUGS AGAINST INFLUENZA VIRUS | 000 | 1 | NIH | 7/19/2006 | $460,957 |
|
| Issue Date FY: 1997 ( Subtotal = $65,690 ) |
| | 1997 | | AUTOIMMUNE TECHNOLOGIES, LLC | 144 ELKS PLACE SUITE 1402 | NEW ORLEANS | LA | 70112-2460 | ORLEANS | USA | R43AR44455 | DIAGNOSTIC TEST FOR CHRONIC FATIGUE AND FIBROMYALGIA | 000 | 01 | NIH | 1/27/1997 | $65,690 |
|
|
